Peripheral Blood Grafts for T Cell–Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome-Reference-Cited by-同舟云学术

Peripheral Blood Grafts for T Cell–Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome

Published:2018-08 Issue:8 Volume:24 Page:1664-1670
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Raj Renju V.,Hamadani Mehdi^ORCID,Szabo Aniko,Pasquini Marcelo C.,Shah Nirav N.,Drobyski William R.,Shaw Bronwen E.,Saber Wael,Rizzo J. Douglas,Jerkins James^ORCID,Fenske Timothy S.,D'Souza Anita,Dhakal Binod,Zhang Chao,Konings Steve,Hari Parameswaran N.^ORCID,Chhabra Saurabh^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Bone-marrow transplantation (first of two parts);Thomas;N Engl J Med,1975

2. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry;Gragert;N Engl J Med,2014

3. Use of partially mismatched related donors extends access to allogeneic marrow transplant;Henslee-Downey;Blood,1997

4. Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation;Ciurea;Biol Blood Marrow Transplant,2012

5. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype;Aversa;N Engl J Med,1998

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide;Leukemia & Lymphoma;2024-05-06

2. Reduced Cytokine Release Syndrome and Improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell Transplantation;Transplantation and Cellular Therapy;2024-04

3. Incidence, risk factors and impact on transplant outcomes of cytokine release syndrome after infusion of haploidentical stem cells with anti-thymocyte globulin;2024-02-07

4. Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-01-04

5. Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy;Blood Advances;2023-08-11